https://www.selleckchem.com/products/azd-9574.html
The mTORC1 activity revealed an association neither to disease severity nor the necessity of treatment; however, p-mTOR inversely correlated with cumulative corticosteroid dosage. Our data confirm activation of the mTORC1 pathway in sarcoidosis, supporting the hypothesis that mTOR is a significant driver in granuloma formation. However, we could not find a relationship between the degree of mTOR activation and disease severity or the need for therapy. Our data confirm activation of the mTORC1 pathway in sarcoidosis, supporting the hypo
Like
Comment
Share
